Transdermal drug delivery systems: A review

Research Journal of Pharmacy and Technology

Volumn 5, Issue 6, 2012, Pages 757-763

  Solanki, Sweta S ^a   Patel, Karan B ^a   Patel, Jalpa G ^a   Patel Dr , Manish P ^a   Patel Dr , Jayvadan K ^a  

^a NOOTAN PHARMACY COLLEGE   (India)

Author keywords

Chemical penetration enhancers; Electroporation; Iontophoresis; Sonophoresis; Transdermal drug delivery system; Types of transdermal patch

Indexed keywords

ALUMINUM; DRUG; ETHYLENE VINYL ACETATE COPOLYMER; EXCIPIENT; LIPOSOME; POLY(4 METHYL 1 PENTENE); POLYETHYLENE; POLYMER; PROLIPOSOME; UNCLASSIFIED DRUG;

ANGINA PECTORIS; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG IN ADHESIVE SYSTEM; DRUG MANUFACTURE; DRUG METABOLISM; DRUG PENETRATION; DRUG QUALITY; DRUG STABILITY; FLATNESS TEST; FOLDING ENDURANCE; HARDNESS; HORMONE SUBSTITUTION; IN VITRO STUDY; MATRIX DISPERSION SYSTEM; MICRORESERVOIR SYSTEM; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PARKINSON DISEASE; PATCH THICKNESS; PATCH WEIGHT; PEEL ADHESION TEST; PERCENTAGE ELONGATION BREAK TEST; PERCENTAGE MOISTURE CONTENT; PERCENTAGE MOISTURE UPTAKE; PH; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POLARISCOPE EXAMINATION; PROBE TACK TEST; QUALITY CONTROL PROCEDURES; QUICK STICK TEST; REVIEW; ROLLING BALL TACK TEST; SHEAR ADHESION TEST; SKIN IRRITATION; SKIN PENETRATION; SMOKING CESSATION; STEADY STATE; STRATUM CORNEUM; SUSTAINED DRUG RELEASE; TENSILE STRENGTH; THUMB TACK TEST; TRANSDERMAL PATCH; TREATMENT INDICATION; VAPOR PATCH; WATER VAPOR PERMEABILITY;

EID: 84863686984     PISSN: 0974360X     EISSN: 09743618     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Ritesh Kumar and Anil Philip, Modified Transdermal Technologies: Breaking the Barriers of Drug Permeation via the Skin, Tropical Journal of Pharmaceutical Research, March 2007, 6(1), 633-644.
2. Debjit Bhowmik, Chiranjib, Margret Chandira, B Jayakar, K.P. Sampath, Recent advances in transdermal drug delivery system, International Journal of Pharm Tech Research, Jan-Mar 2010,2(1), 68-77.
3. M. Anna Wokovich, Transdermal Drug Delivery System (Tdds) Adhesion As A Critical Safety, Efficacy And Quality Attribute, European Journal Of Pharmaceutics And Biopharmaceutics, 2006, 64(1), 1-8.
4. R.L Cleek, A. Bunge, A New Method For Estimating Dermal Absorption From Chemical Exposure. General Approach, Pharm Res, 1993, 10, 497-506.
5. Ro Bi, Dawson TL., The Role Of Sebaceous Gland Activity And Scalp Microfloral Metabolism In The Etiology of Seborrheic Dermatitis And Dandruf. J Investigative Dermatol Sp. 2005; 10(3), 194.
6. Gawkrodger DJ. Dermatology, An Illustrated Colour Text, 3rd Ed., Edinburgh, Churchill Livingstone, 2002.
7. Kewal K. Jain, Methods In Molecular Biology, Vol. 437: Drug Delivery Systems.
8. G.P. Mass, J.C. Dearden, H. Patel, M.T.D. Cronin, Quantitative Structure Permeability Relationships For Percutaneous Absorption, Tox. In.Vit., 2002, 16, 299-317.
9. Y. Frum, M.C. Bonner, M.C, G.M. Eccleston, V.M. Meidan, The Influence Of Drug Partition Coefficient On Follicular Penetration: In Vitro Human Skin Studies, Eur. J. Pharm. Sci., 2007, 30, 280-287.
10. K. Moser, K. Kriwet, A. Naik, Y.N. Kalia, R.H. Guy, Passive Skin Penetration Enhancement And Its Quantification In Vitro, Eur. J. Pharm. Biopharm., 2001, 52, 103-112.
11. Vyas S.P and Khar R.K., Targeted And Controlled Drug Delivery Novel Carrier System, 1st Ed., CBS Publishers And Distributors, New Delhi, 2002, 411-447.
12. Pirot, F., Kalia, Y.N., Stinchcomb, A.L., Keating, G., Bunge, A. and Guy, R.H. (1997), Characterization of the permeability barrier of human skin in vivo. Proc. Nat. Acad. Sci. U.S.A. 94, 1562-1567.
13. Baker W and Heller J., "Material selection for transdermal delivery systems", In Transdermal Drug Delivery: Developmental Issues And Research Initiatives, J. Hadgraft And R.H. Guys, Eds. Marcel Dekker, Inc., New York, 1989, 293-311.
14. Wiechers J., Use of chemical penetration enhancers in transdermal drug delivery-possibilities and difficulties, Acta Pharm, 1992, 4, 123.
15. Yamamoto T, Katakabe K, Akiyoshi K, Kan K and Asano T., Topical application of glibenclamide lowers blood glucose levels in rats, Diabetes Res. Clin. Pract., 1990, 8, 19-22.
16. Al- Khamis K, Davis S.S and Hadgraft J., Microviscosity and drug release from topical gel formulations, Pharm. Res., 1986, 3, 214-217.
17. Anon., Transdermal delivery systems-general drug release standards, Pharmacopeial Forum, 1980, 14, 3860-3865.
18. Mayorga P, Puisieux F and Couarraze G., Formulation study of a transdermal delivery system of primaquine, Int. J. Pharm., 1996, 132, 71-79.
19. Deo M.R, Sant V.P, Parekh S.R, Khopade A.J and Banakar, U.V. proliposome-based transdermal delivery of levonorgestrel, Jour. Biomat, April. 1997, 12, 77-88.
20. Yan-Yu X, Yun-Mei S, Zhi-Peng C and Qi-Nerg P., Preparation of silymarin proliposomes; a new way to increase oral bioavailability of silymarin in beagle dogs, Int. Pharm., 2006, 319, 162-168.
21. Crawford R.R and Esmerian O.K., Effect of plasticizers on some physical properties of cellulose acetate phthalate films, J. Pharm. Sci., 1997, 60, 312-314.
22. J. Ashok Kumar, Nikhila Pullakandam, S. Lakshmana Prabu, V. Gopal., Transdermal Drug Delivery System: An Overview, July - August 2010, 3(2), 49-54.